Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm’s specialty pharmacy arm ...

Walgreens Specialty Pharmacy has expanded its limited distribution drug (LDD) network to now include 265 products, placing it ...

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

Walgreens Specialty Pharmacy, which earned $25.9 billion last year from U.S. prescription revenue, has expanded its limited distribution drug portfolio to 265 medications, the company said Aug. 19. ...

WATERTOWN, New York (WWNY) - A former bank location in Watertown is set to become a specialty pharmacy. According to city ...

When packing for a potential evacuation, experts recommend with an insulated cooler for meds. Use a battery-operated cooler ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.

Omega-3 fatty acids, found in fish such as salmon and sardines, have anti-inflammatory properties, says Vasquez. Other oily ...

Pittsburgh-based Allegheny Health Network recorded an operating income of $64 million (4.5% operating margin), up from an operating loss of $25.9 million (-2.1% margin) during the same period last ...

More research is needed, but anti-inflammatory foods, such as olive oil, fish, and berries, could be worth adding to your ...

MedImpact Holdings is planning to offer an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than Stelara. The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals ...

The company will use the funds to expand EHR and PBM integrations and partner with digital health and other companies to expand medication access.